Figure 1
Figure 1. FAB-M4 and -M5 AML cells produce ROS and express the NADPH oxidase subunit gp91phox. (A) Nonerythroid BM cells recovered at diagnosis from untreated patients with FAB-M1 AML, FAB-M2 AML, or FAB-M4/M5-AML (patients 11-26) were stimulated with PMA (5 × 10−8M) and assayed for ROS production. Bars represent extracellular ROS ± SEM. (B) Myeloid cells in BM or peripheral blood cells from newly diagnosed, untreated AML patients were analyzed by FACS for expression of the NADPH oxidase subunit gp91phox. The data points represent the percentage of CD33+ and/or CD34+ cells expressing gp91phox, with medians indicated. Among FAB-M4/M5 cells, M5 indicates FAB-M5 cells. H.D represents gp91phox expression by peripheral blood monocytes from healthy donors.

FAB-M4 and -M5 AML cells produce ROS and express the NADPH oxidase subunit gp91phox. (A) Nonerythroid BM cells recovered at diagnosis from untreated patients with FAB-M1 AML, FAB-M2 AML, or FAB-M4/M5-AML (patients 11-26) were stimulated with PMA (5 × 10−8M) and assayed for ROS production. Bars represent extracellular ROS ± SEM. (B) Myeloid cells in BM or peripheral blood cells from newly diagnosed, untreated AML patients were analyzed by FACS for expression of the NADPH oxidase subunit gp91phox. The data points represent the percentage of CD33+ and/or CD34+ cells expressing gp91phox, with medians indicated. Among FAB-M4/M5 cells, M5 indicates FAB-M5 cells. H.D represents gp91phox expression by peripheral blood monocytes from healthy donors.

Close Modal

or Create an Account

Close Modal
Close Modal